
A highly favorable political climate for Artificial Intelligence suggests long-term growth, with companies like Rubric (RBRK) providing essential governance tools for the sector. An interventionist foreign policy is expected to drive increased government spending, creating a bullish catalyst for the defense sector. The massive demand for GLP-1 weight loss drugs continues to be a major growth driver for pharmaceutical leaders Novo Nordisk (NVO) and Eli Lilly (LLY). Investors may also consider companies seen as politically aligned, such as Fox Corporation (FOXA), which could benefit from a favorable environment. Conversely, be cautious of companies with large international supply chains due to the significant risk of new tariffs.

By The New York Times
This is what the news should sound like. The biggest stories of our time, told by the best journalists in the world. Hosted by Michael Barbaro, Rachel Abrams and Natalie Kitroeff. Twenty minutes a day, five days a week, ready by 6 a.m. Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. Listen to this podcast in New York Times Audio, our new iOS app for news subscribers. Download now at nytimes.com/audioapp